Adial Pharmaceuticals (ADIL) News Today $0.67 -0.01 (-2.03%) As of 02:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADIL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Q2 EPS Estimate for Adial Pharmaceuticals Lifted by AnalystMay 20, 2025 | americanbankingnews.comAdial Pharmaceuticals Reports First Quarter 2025 Business Update and Financial ResultsMay 17, 2025 | nasdaq.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 15, 2025 | finanznachrichten.deAdial Pharmaceuticals Receives Development Milestone Payment from Adovate Following Phase 1 Clinical Trial Initiation for Asthma TreatmentMay 15, 2025 | nasdaq.comAdial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 15, 2025 | globenewswire.comAdial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 StudyMay 13, 2025 | globenewswire.comAdial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug AdministrationMay 9, 2025 | finance.yahoo.comAdial Pharmaceuticals raises $2.75MMay 7, 2025 | bizjournals.comAdial Pharmaceuticals raises $2.75MMay 7, 2025 | bizjournals.comAdial Pharmaceuticals Secures Patent for Novel Treatment of Alcohol and Opioid Disorders Using AD04 in Genetically Identified PatientsMay 3, 2025 | nasdaq.comAdial Pharmaceuticals secures patent for addiction treatmentMay 2, 2025 | investing.com1ADIL : EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent...May 2, 2025 | benzinga.comAdial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross ProceedsMay 2, 2025 | globenewswire.comAdial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use DisordersMay 1, 2025 | globenewswire.comAdial Pharmaceuticals appoints new COO Tony GoodmanMarch 23, 2025 | uk.investing.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business UpdateMarch 4, 2025 | finanznachrichten.deAdial Pharmaceuticals expects cash to fund operations into 2H of 2025March 4, 2025 | markets.businessinsider.comAdial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business UpdateMarch 4, 2025 | globenewswire.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04February 26, 2025 | finanznachrichten.deAdial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04February 25, 2025 | markets.businessinsider.comAdial says FDA feedback confirms proposed strategy to AD04 Phase 3 formulationFebruary 25, 2025 | markets.businessinsider.comAdial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04February 25, 2025 | globenewswire.comAdial awarded patent covering genetic approach to alcoholism by USPTOFebruary 19, 2025 | markets.businessinsider.comAdial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug DependenciesFebruary 19, 2025 | globenewswire.comAdial Pharmaceuticals awarded new U.S. patent on genotype-specific treatmentFebruary 12, 2025 | markets.businessinsider.comEXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Genotype-Specific Treatment of Opioid-Related DisordersFebruary 12, 2025 | finance.yahoo.comAdial Pharmaceuticals secures new patent for addiction treatmentFebruary 12, 2025 | msn.comAdial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related DisordersFebruary 12, 2025 | globenewswire.comAdial Pharmaceuticals Completes Pharmacokinetics Study of AD04, Prepares for FDA End-of-Phase 2 InteractionJanuary 31, 2025 | nasdaq.comAdial completes key study for alcohol disorder drugJanuary 29, 2025 | msn.comAdial Pharmaceutical Announces Positive Findings From AD04-103 Pharmacokinetics StudyJanuary 29, 2025 | markets.businessinsider.comAdial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderJanuary 29, 2025 | globenewswire.comAdial Pharma stock hits 52-week low at $0.72 amid market challengesJanuary 28, 2025 | msn.comAdial Pharmaceuticals files to sell 5.0M shares of common stock for holdersDecember 21, 2024 | markets.businessinsider.comAdial granted U.S. patent for treatment of alcohol, drug dependenceDecember 3, 2024 | markets.businessinsider.comEXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype CombinationsDecember 3, 2024 | finance.yahoo.comAdial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype CombinationsDecember 3, 2024 | globenewswire.comAdial Pharmaceuticals Advances AD04 with Promising Study ResultsNovember 19, 2024 | markets.businessinsider.comMaxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)November 16, 2024 | markets.businessinsider.comAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | finanznachrichten.deAdial Pharmaceuticals (NASDAQ:ADIL) Stock, Short Interest ReportNovember 15, 2024 | benzinga.comEXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use DisorderNovember 15, 2024 | finance.yahoo.comAdial Pharmaceuticals initiated with a Buy at Rodman & RenshawNovember 15, 2024 | markets.businessinsider.comRodman & Renshaw Initiates Coverage of Adial Pharmaceuticals (ADIL) with Buy RecommendationNovember 15, 2024 | msn.comAdial Pharmaceuticals expects cash to fund operations into second half of 2025November 13, 2024 | markets.businessinsider.comAdial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | markets.businessinsider.comAdial Pharmaceuticals Approves Strategic Changes at Annual MeetingNovember 13, 2024 | markets.businessinsider.comAdial Pharmaceuticals Appoints New Chief Financial OfficerNovember 6, 2024 | markets.businessinsider.comAdial Pharmaceuticals Appoints Vinay Shah as Chief Financial OfficerNovember 5, 2024 | globenewswire.comAdial Pharmaceuticals to Present at the 2024 ThinkEquity ConferenceOctober 23, 2024 | globenewswire.com Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address ADIL Media Mentions By Week ADIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADIL News Sentiment▼0.440.88▲Average Medical News Sentiment ADIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADIL Articles This Week▼21▲ADIL Articles Average Week Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clene News Relmada Therapeutics News Sol-Gel Technologies News NeuroSense Therapeutics News Natural Alternatives International News MIRA Pharmaceuticals News Imunon News Ovid Therapeutics News Longeveron News Q32 Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADIL) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADIL Stock Free ADIL Stock Alerts